Prof. Marc Tischkowitz is a Professor and Honorary NHS Consultant in the Department of Medical Genetics at Cambridge. He completed his medical degree in 1993 and initially trained in Medical Oncology before achieving his Certificate of Completion of Specialist Training (CCST) in Medical Genetics. From 1999 to 2002, he pursued a PhD focusing on the role of Fanconi anemia gene mutations in the development of sporadic acute myeloid leukaemia.

Prof. Tischkowitz held a Consultant post at Great Ormond Street Hospital before moving to McGill University in Montreal in 2005. There, he served on the Faculty for six years before returning to Cambridge. His research has extensively covered Fanconi Anemia genes and hereditary breast cancer predisposition, although his interests span all areas of medical genetics. He is particularly passionate about translating recent advances in genomic technology into clinical practice.

In his current roles, Prof. Tischkowitz is the Cancer Lead for the East Anglian Cancer Genetics service, the Chair of the UK Cancer Genetics Group, and an executive member of the European Reference Network GENTURIS for hereditary cancer syndromes.

His areas of expertise include general genetics for both adults and paediatrics, genetic counselling and testing, medico-legal cases, medical genomics, and cancer genetics. He is skilled in gene variant interpretation and cancer risk assessment. Prof. Tischkowitz is proficient in diagnosing and managing common inherited cancer conditions such as BRCA1, BRCA2, PALB2, and Lynch syndrome, as well as rare inherited cancer conditions, including those affecting paediatric patients.

Appointed to his current position in Cambridge, Prof. Tischkowitz continues to contribute significantly to the field of medical genetics, ensuring that cutting-edge genomic research benefits patients directly.